SHANGHAI and NORTH CHICAGO,Ill.,Jan. 13,2025-- Simcere Zaiming,a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to license agreement
SHANGHAI,Jan. 13,2025-- As the world\'s population grows and industrialization accelerates,the conflict between energy and the environment is intensifying. The search for a balance between energy sup
YIWU,China,Jan. 13,2025-- Yiwu,the world\'s preeminent hub for small commodities,hosts an extensive trading network connecting the globe with 47 industries and 12 million products. As competition in t
Blending Chinese Elements with Grand-scale Illusions in "IMAGINE NATION" Unveiling a Magical Winter for Hong Kong
MELBOURNE,Australiaand INDIANAPOLIS,Jan. 14,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today advises that Dr. Christian Behrenbruch,Managing Director and Group CEO,
HONG KONG,Jan. 10,2025--SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"),an integrated security-related engineering services company in Hong Kong,today annou
